Metabolic syndrome (MetS) is a cluster of cardiovascular (CV) risk factors that includes central obesity, dyslipidemia, hypertension, and disturbed glucose metabolism, is highly prevalent (Ford et al. 2002) and an independent predictor of CV morbidity and mortality (Kipp et al. 2004).